Next Article in Journal
Adverse Events and Safety Profile of the COVID-19 Vaccines in Adolescents: Safety Monitoring for Adverse Events Using Real-World Data
Next Article in Special Issue
mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
Previous Article in Journal
Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection
Previous Article in Special Issue
Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January–March 2022
 
 
Article

Article Versions Notes

Vaccines 2022, 10(5), 743; https://doi.org/10.3390/vaccines10050743
Action Date Notes Link
article pdf uploaded. 9 May 2022 15:56 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/743/pdf-vor
article xml file uploaded 12 May 2022 04:07 CEST Original file -
article xml uploaded. 12 May 2022 04:07 CEST Update https://www.mdpi.com/2076-393X/10/5/743/xml
article pdf uploaded. 12 May 2022 04:07 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/743/pdf
article html file updated 12 May 2022 04:08 CEST Original file -
article html file updated 2 August 2022 22:59 CEST Update https://www.mdpi.com/2076-393X/10/5/743/html
Back to TopTop